Which is better for weight loss Ozempic (or Wegovy) or Mounjaro?
* required field
* required field
Angelika Talar-Śpionek Pharmacist, Editor
7 months ago
As research shows, due to its complex mechanism of action, tirzepatide (Mounjaro) is supposed to be more effective than the popular and widely used semaglutide (Wegovy).
Tirzepatide treatment has been shown to be associated with clinically significant and sustained (up to 72 weeks) weight reduction compared to placebo. The mean weight loss at week 72 of tirzepatide 10 mg and 15 mg was confirmed to be 12.8 and 14.7 mg, respectively, compared to 3.2% for placebo. At least a 5% decrease was achieved by about 80% of patients in the study groups. The most common adverse reactions included nausea, diarrhoea and vomiting already known from previous studies, and were predominantly mild to moderate, with few events leading to treatment discontinuation.
For the semaglutide injections, the average weight loss after 16 weeks was about 6.4% at a dose of 0.5 mg and about 8.6% at a dose of 1.0 mg of the drug.
Since, in addition to acting on GLP-1 receptors (Ozempic, Wegovy works on them), tirzepatide (Mounjaro) also acts on GIP receptors - it may prove to be more effective.
As research shows, Tirzepatide allows for a statistically significant reduction in body weight and fat content in the body without affecting the composition of muscle tissue.
It has been shown that during clinical trials of tirzepatide lasting 72 weeks (1.5 years), a weight loss of more than 5 kg more was observed compared to the semaglutide group.
Ozempic is not a drug approved for patients with obesity to lose weight. More here:
Here you can check the availability of Mounjaro and Wegovy in pharmacies and make a reservation:
https://www.gdziepolek.pl/produkty/118410/mounjaro-iniekcja/apteki
https://www.gdziepolek.pl/produkty/115667/wegovy-iniekcja/apteki
I've attached links to helpful posts: